Mechanisms of Fetal and Neonatal Renal Impairment by Pharmacologic Inhibition of Angiotensin

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|27|4572-4580

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.27, 2012-09, pp. : 4572-4580

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Organ Impairment—Drug–Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of Drugs

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 8, 2015-08 ,pp. : 489-494

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade

By Parvanova Aneliya   Chiurchiu Carlos   Ruggenenti Piero   Remuzzi Giuseppe  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1931-1942

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1543-1556

Informa Healthcare

Access to resources Recommend Favorite

Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues

By Arun B.   Frenkel E.P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 491-505

Informa Healthcare

Access to resources Recommend Favorite

Prospects for Pharmacologic Inhibition of Hepatic Glucose Production

By  

Current Medicinal Chemistry, Vol. 10, Iss. 2, 2003-01 ,pp. : 99-121

Bentham Science Publishers

Access to resources Recommend Favorite